1-9 of 9
Klaus Rostgaard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Emelie Curovic Rotbain, MD, Carsten Utoft Niemann, MD PhD Ass. Prof, Klaus Rostgaard, MSc., Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, MD Dr.MD, Henrik Frederiksen, MD Prof
Journal: Blood
Blood (2019) 134 (Supplement_1): 4285.
DOI: https://doi.org/10.1182/blood-2019-122673
Published: 2019
Journal Articles

IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis

Emelie Curovic Curovic Rotbain, MD, Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, Klaus Rostgaard, MSc., Michael A Andersen, MD, Carsten Utoft Niemann, MD PhD, Henrik Frederiksen, associate professor, consultant, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1742.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1742.1742
Published: 2017
Journal Articles

Increased Risk of Second Hematological and Non-Hematological Malignancies in CLL Patients Treated with Chemotherapy As Compared to Untreated Patients and Matched Controls - Results from a Danish Population Based Study

Caspar Da Cunha-Bang, Klaus Rostgaard, Jacob Simonsen, Christian H Geisler, Henrik Hjalgrim, Henrik Frederiksen, MD PhD, Kirsten Grønbæk, Carsten Utoft Niemann
Journal: Blood
Blood (2016) 128 (22): 3219.
DOI: https://doi.org/10.1182/blood.V128.22.3219.3219
Published: 2016
Journal Articles

Lack of association between blood donor age and survival of transfused patients

Senthil K. Vasan, Flaminia Chiesa, Klaus Rostgaard, Patrik K. E. Magnusson, Märit Halmin, Kaspar René Nielsen, Kjell Einar Titlestad, Henrik Hjalgrim, Gustaf Edgren
Journal: Blood
Blood (2016) 127 (5): 658–661.
DOI: https://doi.org/10.1182/blood-2015-11-683862
Published: 2016
Journal Articles

Improved Survival for Patients with CLL in the Era of Combination Chemoimmunotherapy - a Danish Population Based Study

Caspar da Cunha-Bang, Jacob Simonsen, Klaus Rostgaard, Christian H Geisler, Henrik Hjalgrim, Carsten Niemann
Journal: Blood
Blood (2015) 126 (23): 1740.
DOI: https://doi.org/10.1182/blood.V126.23.1740.1740
Published: 2015
Journal Articles

No evidence of transmission of chronic lymphocytic leukemia through blood transfusion

Clinical Trials & Observations Brief Report
Henrik Hjalgrim, Klaus Rostgaard, Senthil K. Vasan, Henrik Ullum, Christian Erikstrup, Ole B. V. Pedersen, Kaspar R. Nielsen, Kjell-Einar Titlestad, Mads Melbye, Olof Nyrén, Gustaf Edgren
Journal: Blood
Blood (2015) 126 (17): 2059–2061.
DOI: https://doi.org/10.1182/blood-2015-03-632844
Published: 2015
Journal Articles

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Wendy Cozen, D.O., M.P.H., Dalin Li, M.D., Ph.D., Maria Timofeeva, Ph.D., Arjan Diepstra, MD PhD, Dennis Hazelett, Ph.D., Manon Delahaye-Sourdeix, M.S., Christopher K. Edlund, M.S., Klaus Rostgaard, Ph.D., David J. Van Den Berg, Ph.D., Lude Franke, Ph.D., Karin Eckstrom Smedby, M.D., Ph.D., Sally L. Glaser, Ph.D., Harm-Jam Westra, Ph.D., Leslie L. Robison, PhD, Thomas M. Mack, M.D., M.P.H., Herve Ghesquieres, MD, PhD, Amie E. Hwang, Ph.D., M.P.H., Alexandra Nieters, Ph.D., Silvia de Sanjosé, M.D., Ph.D., Victoria K. Cortessis, Ph.D., Tracy Lightfoot, Nikolaus Becker, M.D., Ph.D., Marc Maynadie, MD, PhD, Lenka Foretova, Ph.D., Eve Roman, Ph.D., Yolanda Benavente, Ph.D., Bharat N. Nathwani, M.D., Bengt Glimelius, M.D., Ph.D., Anthony Staines, M.D., Ph.D., Paolo Boffetta, M.D., M.P.H., Brian K Link, MD, L. A. Kiemeney, Ph.D., Stephen M Ansell, M.D.Ph.D., Smita Bhatia, Ph.D., Louise C Strong, Ph.D., Pilar Galan, M.D., Lars Vatten, M.D., Ph.D., Thomas M Habermann, MD, Eric J. Duell, Ph.D., M.S., Annette Lake, M.S., Rianne Veenstra, Lydia Visser, PhD, Kevin Urayama, Ph.D., Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, M.D, Graham Byrnes, Ph.D., Mark Lathrop, PhD, Hans-Olov Adami, M.D., Ph.D., Mads Melbye, MD, DMSc, James R Cerhan, MD, PhD, Alice Gallagher, M.D., G. Malcolm Taylor, MD, Susan L Slager, PhD, Paul Brennan, Ph.D., David V. Conti, Ph.D., Gerhard Coetzee, Ph.D., Kenan Onel, MD, PhD, Ruth F. Jarrett, M.D., Ph.D., Henrik Hjalgrim, M.D., Ph.D., Anke Van Den Berg, PhD, James D. McKay, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 626.
DOI: https://doi.org/10.1182/blood.V122.21.626.626
Published: 2013
Journal Articles

Risk of EBV-Positive Hodgkin Lymphoma Varies Over 30-Fold by HLA Class I Genotype and History of Infectious Mononucleosis.

Ruth Jarrett, MBChB, FRCP, FRCPath, Paul CD Johnson, Klaus Rostgaard, Annette Lake, BSc(Hons), Lesley Shield, BSc(Hons), Ann-Margaret Little, Karin Ekstrom-Smedby, Hans Olov Adami, Bengt Glimelius, Stephen Hamilton Dutoit, Eleanor Kane, G. Malcolm Taylor, Alex McConnachie, Lars P Ryder, Christer Sundstrom, Paal Skytt Andersen, Ellen T Chang, Freda Alexander, Mads Melbye, Henrik Hjalgrim
Journal: Blood
Blood (2009) 114 (22): 269.
DOI: https://doi.org/10.1182/blood.V114.22.269.269
Published: 2009
Journal Articles

Borrelia infection and risk of non-Hodgkin lymphoma

Clinical Trials & Observations
Claudia Schöllkopf, Mads Melbye, Lars Munksgaard, Karin Ekström Smedby, Klaus Rostgaard, Bengt Glimelius, Ellen T. Chang, Göran Roos, Mads Hansen, Hans-Olov Adami, Henrik Hjalgrim
Journal: Blood
Blood (2008) 111 (12): 5524–5529.
DOI: https://doi.org/10.1182/blood-2007-08-109611
Published: 2008